Change in PDE10 across early Huntington disease assessed by [18F]MNI-659 and PET imaging

Neurology
David S RussellKenneth L Marek

Abstract

To evaluate whether striatal [(18)F]MNI-659 PET imaging of phosphodiesterase 10A (PDE10) serves as a sensitive and reliable biomarker of striatal neurodegeneration in a longitudinal cohort of participants with early Huntington disease (HD). A cohort of participants with HD, including both participants premanifest or manifest with motor signs, underwent clinical assessments, genetic determination, and 2 [(18)F]MNI-659 PET imaging sessions approximately 1 year apart. Eleven healthy control (HC) participants underwent clinical assessments and [(18)F]MNI-659 PET imaging once. Striatal binding potentials (BPnd) were estimated for brain regions of interest, specifically within the basal ganglia, and compared between baseline and follow-up imaging. Clinical measures of HD severity were assessed at each visit. Eight participants with HD (6 manifest; 2 premanifest) participated. Of those with manifest HD, all had relatively early stage disease (stage 1, n = 2; stage 2, n = 4) and a Unified Huntington's Disease Rating Scale total motor score <45. As expected, the HD cohort as a whole had a reduction in the basal ganglia BPnd to approximately 50% of that seen in HC. On follow-up scans, [(18)F]MNI-659 uptake declined in the putamen and cau...Continue Reading

References

Jan 1, 1979·Neurology·I Shoulson, S Fahn
Aug 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·A ReinerA B Young
Mar 1, 1996·Movement Disorders : Official Journal of the Movement Disorder Society
Mar 18, 2004·Clinical Genetics·D R LangbehnUNKNOWN International Huntington's Disease Collaborative Group
Dec 22, 2004·The European Journal of Neuroscience·Haibei HuEileen M Denovan-Wright
Jan 13, 2006·Journal of Neurochemistry·Paula A DesplatsElizabeth A Thomas
May 1, 2007·Progress in Neurobiology·Jang-Ho J Cha
Sep 18, 2010·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Sofie CelenGuy Bormans
Dec 18, 2010·Lancet Neurology·Christopher A Ross, Sarah J Tabrizi
May 24, 2011·Lancet Neurology·David W WeirBlair R Leavitt
Dec 6, 2011·Lancet Neurology·Karl Kieburtz, Charles Venuto
Jun 19, 2013·Trends in Biochemical Sciences·John Labbadia, Richard I Morimoto
Sep 21, 2013·Nature Reviews. Neuroscience·Mahmoud A PouladiMichael R Hayden
Jun 6, 2014·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Olivier BarretGilles Tamagnan

❮ Previous
Next ❯

Citations

Feb 24, 2016·European Journal of Nuclear Medicine and Molecular Imaging·Gennaro PaganoMarios Politis
Apr 3, 2016·The International Journal of Neuropsychopharmacology·Pim R A HeckmanJos Prickaerts
May 24, 2016·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Susann SchröderPeter Brust
Aug 20, 2016·Journal of the Neurological Sciences·Heather WilsonMarios Politis
Aug 17, 2016·Brain Pathology·Mar PuigdellívolEsther Pérez-Navarro
Apr 11, 2017·Movement Disorders : Official Journal of the Movement Disorder Society·Michel KooleWim Vandenberghe
Feb 15, 2017·Frontiers in Neurology·Heather WilsonMarios Politis
Sep 5, 2017·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Ana M GarcíaCarmen Gil
Sep 22, 2019·European Journal of Nuclear Medicine and Molecular Imaging·Stuart P McCluskeyOliver Howes
Jan 23, 2020·Movement Disorders : Official Journal of the Movement Disorder Society·Patrik FazioUNKNOWN PEARL-HD and LONGPDE10 study collaborators
Jan 26, 2020·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Klaudia CybulskaMark Rijpkema
Sep 11, 2017·Journal of Neurology, Neurosurgery, and Psychiatry·Flavia NiccoliniMarios Politis
Mar 8, 2017·Current Neurology and Neuroscience Reports·Tiago A Mestre, Cristina Sampaio
Mar 3, 2018·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Susann SchröderPeter Brust
Dec 25, 2019·Proceedings of the National Academy of Sciences of the United States of America·Gonzalo S TejedaGeorge S Baillie
Oct 7, 2018·Current Neurology and Neuroscience Reports·Patrik FazioAndrea Varrone
Aug 8, 2019·Nature Reviews. Drug Discovery·George S BaillieMichy P Kelly
Jun 27, 2017·Journal of Clinical Movement Disorders·Debra J Ehrlich, Ruth H Walker
Dec 19, 2020·Movement Disorders : Official Journal of the Movement Disorder Society
Jan 28, 2021·Seminars in Nuclear Medicine·Aren van WaardeRudi A J O Dierckx
Apr 14, 2021·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Adam J Schwarz
May 28, 2021·Journal of Medicinal Chemistry·Jiyun SunSteven H Liang
Jun 23, 2021·Movement Disorders : Official Journal of the Movement Disorder Society·Roberto ErroKailash P Bhatia
Nov 12, 2020·Stem Cells·Anne-Catherine Bachoud-LéviAnne Rosser

❮ Previous
Next ❯

Related Concepts

Related Feeds

Basal Ganglia

Basal Ganglia are a group of subcortical nuclei in the brain associated with control of voluntary motor movements, procedural and habit learning, emotion, and cognition. Here is the latest research.